Carbamylome analysis reveals regulatory roles for lysine carbamylation in β-cell glycolytic and insulin-processing enzymes
Year: 2026
Type: article
Abstract: In type 1 diabetes (T1D), insulin-producing β cells are destroyed by an autoimmune response driven by pro-inflammatory cytokines. The signaling of these cytokines is partially mediated by post-translational modifications, such as phosphorylation and acetylation. However, the role of other post-translational modifications in β-cell cytokine signaling represents an important knowledge gap. In the context of autoimmune diseases, lysine carbamylation has gained attention for its role in pathogenesis. Here, we investigate possible roles of carbamylation in T1D. We found that pancreata from the T1D model, non-obese diabetic (NOD) mice, at pre-diabetic stage (8-9 weeks old) exhibit 11% carbamylation-positive β cells, whereas non-diabetic CD1 mice have only 5%. Proteomics analysis of the MIN6 insulin-producing cell line treated with a cocktail of three pro-inflammatory cytokines IFNγ + IL-1β + TNFα identified 284 carbamylated peptides from 222 proteins regulated by the cytokine treatment. Integration of carbamylation and acetylation provided a deep view of the cytokine-regulated PTMs and potential points of interplay. A functional-enrichment analysis revealed that carbamylation was enriched in pathways related to autoimmune diseases, metabolism, DNA replication, and protein translation. Moreover, functional testing demonstrated that carbamylation inhibits the glycolytic enzyme aldolase A and the insulin-processing enzyme carboxypeptidase E, identifying a possible role for cytokine-induced β-cell dysfunction. In summary, NOD mice have more carbamylated β cells than CD1 mice, and pro-inflammatory cytokine treatment regulates protein carbamylation in MIN6 cells. These data identified carbamylation as a potential regulatory mechanism for β-cell metabolism and insulin production in insulitis.
Source: Biochemical Journal
DOI: 10.1042/bcj20260414
Authors: Youngki You, Hyeyoon Kim, Mereena G. Ushakumary, Marina A. Gritsenko, Hanna E. Walukiewicz, Fangjia Li, Jerry Xu, Ivo Diaz Ludovico, Panshak P. Dakup, Wei-Jun Qian, Geremy C. Clair, Gina M. Many, Raghavendra G. Mirmira, Bobbie-Jo M. Webb-Robertson, Alan J Wolfe, Christopher V. Rao, Emily K. Sims, Lori Sussel, Ernesto S. Nakayasu
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Awards: G3171598069, G3544627429, Beta cell extracellular vesicles in health and disease, G5726405315, G832612391, G8879758613, Interferon Signaling in the T1D Islet Microenvironment, Systematic validation of biomarkers predictive of IA and T1D and their relationship with disease development, Transcriptional and Translational Mechanisms Governing Beta Cell Function, Implications of Changes in Islet Exosomal Cargo in Type 1 Diabetes, Alternative RNA splicing events contribute to the onset of islet dysfunction in T1D
OpenAlex ID: W7163006091
